Cineverse Corp (CNVS) reports impressive revenue growth and outlines future strategies amid the success of "Terrifier 3".

Cineverse (NASDAQ: CNVS), a next-gen entertainment studio, and Bloody Disgusting, its horror division, have announced today ...

In recent trading, Cineverse Corp (CNVS) stock price has shown some volatility, fluctuating 17.22% over the last five trades and 67.54% over the past 30 trades. This represents a notable shift from ...

AMSBIO’s CancerSeq™ FFPE tissues provide pre-screened tumour samples validated for single nucleotide polymorphisms (SNPs), ...

Q2 2025 Earnings Call Transcript November 14, 2024 Operator: Good day, everyone. Welcome to Cineverse’s Second Quarter Fiscal 2025 Financial Results Conference Call. My name is Mikaya [ph] and I will ...

Good day, everyone. Welcome to Cineverse's Second Quarter Fiscal 2025 Financial Results Conference Call. My name is Mikaya [ph] and I will be your operator today. Currently, all participants are ...

Analysts are estimating that Cineverse will report an earnings per share (EPS) of $-0.08. Cineverse bulls will hope to hear ...

Cineverse Corp. ( (CNVS) ) has released its Q2 earnings. Here is a breakdown of the information Cineverse Corp. presented to its investors.

Benchmark raised the firm’s price target on Cineverse (CNVS) to $10 from $9 and keeps a Speculative Buy rating on the shares. Cineverse ...